Prescription Drugs: Companies Typically Charge More in the United States Than in the United Kingdom
HEHS-94-29
Published: Jan 12, 1994. Publicly Released: Feb 02, 1994.
Skip to Highlights
Highlights
Pursuant to a congressional request, GAO reviewed the extent to which drug manufacturers charge more for the same products in the United States than abroad, focusing on: (1) manufacturers' factory prices; (2) brand-name drug prices; and (3) the market segment in which retail pharmacies generally do not receive manufacturers' discounts.
Full Report
Office of Public Affairs
Topics
Comparative analysisCost analysisDrugsFederal regulationsForeign governmentsHealth care cost controlPharmaceutical industryPharmacological researchPrice fixingPrice regulationPrescription drugs